[1] Qiu J,Söderlund-Venermo M,Young NS.Human parvoviruses[J]. Clin Microbiol Rev,2017,30(1):43-113. [2] Eid AJ,Ardura MI,AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation:guidelines from the American Society of Transplantation Infe-ctious Diseases Community of Practice[J]. Clin Transplant,2019,33(9):e13535. [3] Nouri M,Kamakifar P,Khodabandehlou N,et al.Association between parvovirus B19 and anemia in HIV-infected patients[J]. Med J Islam Repub Iran,2019,33:137. [4] 张晓伟. 肾移植术后微小病毒B19感染的临床研究[D]. 上海:中国人民解放军海军军医大学,2020. Zhang XW.Clinical study of parvovirus B19 infection after renal transplantation[D]. Shanghai:Naval Medical University,2020. [5] Patil MR,Choudhury AR,Chohwanglim M,et al.Post renal transplant pure red cell aplasia is tacrolimus a culprit?[J]. Clin Kidney J,2016,9(4):603-605. [6] 李乐之,路潜. 外科护理学[M]. 6版. 北京:人民卫生出版社,2017:192-193. Li LZ,Lu Q.Surgical nursing[M]. 6th Ed. Beijing:People's Medical Publishing House,2017:192-193. [7] 李纳,汤姝,朱振峰,等. 肾移植术后应用咪唑立宾和吗替麦考酚酯的有效性和安全性Meta分析[J]. 中国医院药学杂志,2018,38(10):1102-1109. Li N,Tang S,Zhu ZF,et al.Efficacy and safety of mizoribine and mycophenolate mofetil after renal transplantation:a Meta-analysis[J]. Chin J Hosp Pharm,2018,38(10):1102-1109. [8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 痛风及高尿酸血症基层诊疗指南(2019年)[J]. 中华全科医师杂志,2020,19(4):293-303. Chinese Medical Association,Chinese Medical Association Magazine,General Medicine Branch of Chinese Medical Association,etc. Guidelines for primary diagnosis and treatment of gout and hyperuricemia(2019)[J]. Chin J Gen Pract,2020,19(4):293-303. [9] Šutová I,Chovancova Z,Litzman J.Adverse effects of immunoglobulin therapy[J]. Vnitr Lek,2019,65(2):131-132. [10] Rosado-Canto R,Carrillo-Pérez DL,Jiménez JV,et al.Treatment strategies and outcome of parvovirus b19 infection in kidney transplant recipients:a case series and literature review of 128 patients[J]. Rev Invest Clin,2019,71(4):265-274. |